 Christopher Lowry
Concepts (714)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 63 | 2025 | 294 | 9.940 |
Why?
| | Raphe Nuclei | 41 | 2019 | 111 | 8.810 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 54 | 5.810 |
Why?
| | Mycobacterium | 13 | 2024 | 116 | 5.070 |
Why?
| | Mycobacteriaceae | 15 | 2025 | 35 | 4.540 |
Why?
| | Serotonergic Neurons | 17 | 2025 | 29 | 4.510 |
Why?
| | Stress, Psychological | 37 | 2025 | 1148 | 4.300 |
Why?
| | Anxiety | 46 | 2024 | 1122 | 4.220 |
Why?
| | Dorsal Raphe Nucleus | 15 | 2025 | 31 | 3.510 |
Why?
| | Proto-Oncogene Proteins c-fos | 24 | 2025 | 194 | 3.240 |
Why?
| | Amygdala | 21 | 2022 | 198 | 3.150 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 72 | 3.140 |
Why?
| | Neurons | 44 | 2022 | 1639 | 3.080 |
Why?
| | Rats | 84 | 2025 | 5570 | 3.050 |
Why?
| | Gastrointestinal Microbiome | 21 | 2025 | 771 | 3.000 |
Why?
| | Behavior, Animal | 27 | 2025 | 521 | 2.990 |
Why?
| | Fear | 16 | 2023 | 366 | 2.970 |
Why?
| | Corticosterone | 25 | 2025 | 242 | 2.950 |
Why?
| | Microbiota | 17 | 2025 | 782 | 2.780 |
Why?
| | Animals | 179 | 2025 | 37948 | 2.350 |
Why?
| | Stress Disorders, Post-Traumatic | 15 | 2025 | 889 | 2.220 |
Why?
| | Hyperthermia, Induced | 8 | 2024 | 120 | 2.070 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 28 | 2.070 |
Why?
| | Rats, Wistar | 34 | 2020 | 449 | 1.960 |
Why?
| | Probiotics | 4 | 2025 | 61 | 1.920 |
Why?
| | Inflammation | 28 | 2025 | 2870 | 1.900 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 477 | 1.880 |
Why?
| | Rats, Sprague-Dawley | 35 | 2025 | 2521 | 1.820 |
Why?
| | Pituitary-Adrenal System | 12 | 2019 | 163 | 1.820 |
Why?
| | Antidepressive Agents | 10 | 2024 | 248 | 1.810 |
Why?
| | Hypothalamo-Hypophyseal System | 13 | 2019 | 196 | 1.790 |
Why?
| | Extinction, Psychological | 4 | 2023 | 91 | 1.750 |
Why?
| | Central Nervous System | 10 | 2022 | 279 | 1.610 |
Why?
| | Organic Cation Transport Proteins | 10 | 2025 | 25 | 1.570 |
Why?
| | Anxiety Disorders | 11 | 2021 | 370 | 1.550 |
Why?
| | Mental Health | 8 | 2024 | 792 | 1.530 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 62 | 1.510 |
Why?
| | Brain | 29 | 2024 | 2934 | 1.490 |
Why?
| | Panic Disorder | 7 | 2017 | 22 | 1.420 |
Why?
| | Hippocampus | 9 | 2025 | 966 | 1.380 |
Why?
| | Fluoxetine | 7 | 2025 | 54 | 1.330 |
Why?
| | Male | 140 | 2025 | 72431 | 1.270 |
Why?
| | Hypothalamus | 7 | 2025 | 160 | 1.260 |
Why?
| | Motor Activity | 12 | 2021 | 723 | 1.250 |
Why?
| | Glucocorticoids | 6 | 2023 | 528 | 1.190 |
Why?
| | Microglia | 6 | 2023 | 269 | 1.180 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 63 | 1.170 |
Why?
| | RNA, Ribosomal, 16S | 14 | 2025 | 564 | 1.160 |
Why?
| | Depression | 14 | 2025 | 1561 | 1.120 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 854 | 1.110 |
Why?
| | Analysis of Variance | 23 | 2018 | 1301 | 1.090 |
Why?
| | Citalopram | 2 | 2018 | 32 | 1.070 |
Why?
| | Social Isolation | 3 | 2013 | 73 | 1.050 |
Why?
| | Urocortins | 10 | 2019 | 24 | 1.050 |
Why?
| | Neural Pathways | 13 | 2025 | 311 | 1.040 |
Why?
| | Carbolines | 9 | 2015 | 35 | 1.030 |
Why?
| | Depressive Disorder | 3 | 2018 | 386 | 1.030 |
Why?
| | Feces | 8 | 2025 | 513 | 1.020 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 70 | 1.020 |
Why?
| | Environment, Controlled | 3 | 2016 | 23 | 1.010 |
Why?
| | Salamandridae | 11 | 2009 | 33 | 0.980 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 107 | 0.980 |
Why?
| | Tryptophan | 9 | 2022 | 175 | 0.970 |
Why?
| | Mood Disorders | 3 | 2013 | 140 | 0.950 |
Why?
| | Immunomodulation | 3 | 2016 | 98 | 0.940 |
Why?
| | Dysbiosis | 2 | 2018 | 187 | 0.930 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1705 | 0.930 |
Why?
| | Social Behavior | 8 | 2025 | 287 | 0.910 |
Why?
| | Cell Count | 14 | 2015 | 320 | 0.910 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 27 | 0.900 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 47 | 0.900 |
Why?
| | Disease Models, Animal | 20 | 2023 | 4539 | 0.890 |
Why?
| | Panic | 4 | 2017 | 8 | 0.850 |
Why?
| | Diet, Western | 1 | 2024 | 86 | 0.830 |
Why?
| | RNA, Messenger | 9 | 2020 | 2815 | 0.820 |
Why?
| | Stress, Physiological | 11 | 2014 | 451 | 0.820 |
Why?
| | Toxoplasmosis | 5 | 2025 | 43 | 0.810 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.810 |
Why?
| | Veterans | 8 | 2025 | 1614 | 0.800 |
Why?
| | Arousal | 6 | 2023 | 157 | 0.790 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 36 | 0.770 |
Why?
| | Maternal Deprivation | 4 | 2019 | 16 | 0.760 |
Why?
| | Septal Nuclei | 3 | 2019 | 24 | 0.760 |
Why?
| | Weight Gain | 3 | 2024 | 557 | 0.750 |
Why?
| | Inflammation Mediators | 3 | 2018 | 503 | 0.740 |
Why?
| | Caffeine | 5 | 2018 | 74 | 0.740 |
Why?
| | Immunization | 9 | 2022 | 374 | 0.730 |
Why?
| | Reflex, Startle | 4 | 2019 | 75 | 0.720 |
Why?
| | Mental Disorders | 9 | 2024 | 1154 | 0.710 |
Why?
| | Neurons, Afferent | 4 | 2012 | 102 | 0.710 |
Why?
| | Carbon Dioxide | 4 | 2010 | 239 | 0.700 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 205 | 0.700 |
Why?
| | Toxoplasma | 4 | 2025 | 49 | 0.700 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 331 | 0.690 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 451 | 0.690 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 24 | 0.680 |
Why?
| | Veterans Health | 2 | 2024 | 189 | 0.680 |
Why?
| | Hot Temperature | 3 | 2022 | 410 | 0.660 |
Why?
| | Mice | 34 | 2025 | 18261 | 0.650 |
Why?
| | Colitis | 4 | 2019 | 280 | 0.630 |
Why?
| | Exploratory Behavior | 5 | 2021 | 85 | 0.620 |
Why?
| | Proteome | 1 | 2025 | 515 | 0.620 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.620 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1251 | 0.620 |
Why?
| | Body Temperature | 5 | 2024 | 226 | 0.620 |
Why?
| | Humans | 98 | 2025 | 144667 | 0.620 |
Why?
| | Environment Design | 2 | 2016 | 26 | 0.600 |
Why?
| | Interleukin-4 | 1 | 2020 | 206 | 0.580 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.580 |
Why?
| | Locomotion | 6 | 2021 | 102 | 0.570 |
Why?
| | Emotions | 5 | 2023 | 578 | 0.570 |
Why?
| | Synaptic Transmission | 4 | 2018 | 292 | 0.570 |
Why?
| | Dominance-Subordination | 2 | 2011 | 16 | 0.560 |
Why?
| | Porphyromonas gingivalis | 3 | 2025 | 23 | 0.560 |
Why?
| | Genes, fos | 2 | 2010 | 36 | 0.540 |
Why?
| | Catecholamines | 3 | 2005 | 87 | 0.540 |
Why?
| | Interleukin-6 | 5 | 2024 | 770 | 0.540 |
Why?
| | Blood Proteins | 1 | 2020 | 230 | 0.540 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 241 | 0.530 |
Why?
| | Housing, Animal | 2 | 2016 | 46 | 0.530 |
Why?
| | Behavior | 1 | 2018 | 90 | 0.530 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2591 | 0.520 |
Why?
| | Swimming | 3 | 2021 | 53 | 0.520 |
Why?
| | Signal Transduction | 5 | 2025 | 5185 | 0.520 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.510 |
Why?
| | Proteomics | 2 | 2025 | 1183 | 0.510 |
Why?
| | Hypothermia | 1 | 2017 | 52 | 0.500 |
Why?
| | Hypercapnia | 4 | 2012 | 53 | 0.500 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 906 | 0.500 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 207 | 0.500 |
Why?
| | Psychological Trauma | 1 | 2017 | 57 | 0.500 |
Why?
| | Prebiotics | 3 | 2024 | 28 | 0.490 |
Why?
| | Pets | 3 | 2025 | 26 | 0.490 |
Why?
| | Vaccination | 3 | 2020 | 1419 | 0.490 |
Why?
| | Military Personnel | 3 | 2019 | 733 | 0.490 |
Why?
| | Parvalbumins | 2 | 2020 | 26 | 0.480 |
Why?
| | Immune System | 2 | 2014 | 178 | 0.480 |
Why?
| | Lipid Metabolism | 1 | 2020 | 524 | 0.470 |
Why?
| | Circadian Rhythm | 4 | 2021 | 510 | 0.470 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5967 | 0.460 |
Why?
| | Suicide, Attempted | 4 | 2025 | 421 | 0.450 |
Why?
| | Bacteria | 7 | 2025 | 894 | 0.450 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 3 | 0.440 |
Why?
| | Gene Expression | 8 | 2020 | 1476 | 0.440 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.440 |
Why?
| | Brain Concussion | 2 | 2020 | 640 | 0.440 |
Why?
| | Social Determinants of Health | 1 | 2018 | 305 | 0.420 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 184 | 0.410 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 107 | 0.400 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 5 | 0.400 |
Why?
| | Cytokines | 7 | 2023 | 2045 | 0.400 |
Why?
| | Conditioning, Classical | 5 | 2020 | 119 | 0.400 |
Why?
| | Intestines | 2 | 2014 | 357 | 0.390 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 394 | 0.380 |
Why?
| | Pons | 2 | 2010 | 33 | 0.380 |
Why?
| | Mesencephalon | 2 | 2010 | 65 | 0.380 |
Why?
| | GABA Antagonists | 6 | 2013 | 34 | 0.370 |
Why?
| | Life Style | 2 | 2014 | 481 | 0.370 |
Why?
| | Public Health | 2 | 2022 | 569 | 0.370 |
Why?
| | Sex Characteristics | 2 | 2013 | 776 | 0.360 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 718 | 0.360 |
Why?
| | Diet, High-Fat | 3 | 2024 | 261 | 0.350 |
Why?
| | Prosencephalon | 6 | 2018 | 53 | 0.350 |
Why?
| | Cold Temperature | 1 | 2013 | 208 | 0.350 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.350 |
Why?
| | Immunoglobulin G | 5 | 2025 | 886 | 0.350 |
Why?
| | GABAergic Neurons | 1 | 2012 | 37 | 0.350 |
Why?
| | Kynurenine | 5 | 2018 | 103 | 0.340 |
Why?
| | Time Factors | 12 | 2015 | 7140 | 0.340 |
Why?
| | Female | 45 | 2025 | 78304 | 0.340 |
Why?
| | DNA, Bacterial | 3 | 2024 | 347 | 0.340 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 194 | 0.340 |
Why?
| | Brain Mapping | 5 | 2007 | 535 | 0.340 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 2019 | 0.340 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 127 | 0.330 |
Why?
| | Aging | 5 | 2024 | 1938 | 0.330 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1322 | 0.320 |
Why?
| | Suicidal Ideation | 3 | 2025 | 575 | 0.320 |
Why?
| | Bronchi | 1 | 2012 | 263 | 0.320 |
Why?
| | Third Ventricle | 1 | 2010 | 16 | 0.310 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 168 | 0.310 |
Why?
| | Light | 3 | 2008 | 405 | 0.310 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2365 | 0.300 |
Why?
| | Animals, Newborn | 5 | 2018 | 890 | 0.300 |
Why?
| | Interneurons | 1 | 2010 | 125 | 0.300 |
Why?
| | Suicide | 4 | 2020 | 725 | 0.290 |
Why?
| | Fenfluramine | 1 | 2009 | 17 | 0.290 |
Why?
| | Sequence Analysis, DNA | 2 | 2024 | 828 | 0.290 |
Why?
| | Amish | 2 | 2019 | 7 | 0.280 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 43 | 0.280 |
Why?
| | Antibodies, Protozoan | 4 | 2025 | 41 | 0.280 |
Why?
| | Brain Chemistry | 4 | 2007 | 116 | 0.280 |
Why?
| | Medulla Oblongata | 4 | 2012 | 37 | 0.270 |
Why?
| | Cognition | 4 | 2022 | 1263 | 0.270 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 57 | 0.270 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 580 | 0.270 |
Why?
| | Schizophrenia | 3 | 2016 | 443 | 0.260 |
Why?
| | RNA, Bacterial | 2 | 2020 | 193 | 0.260 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 130 | 0.260 |
Why?
| | Pregnancy Trimester, First | 2 | 2025 | 136 | 0.260 |
Why?
| | Encephalitis | 2 | 2020 | 142 | 0.260 |
Why?
| | Sleep Deprivation | 2 | 2020 | 206 | 0.260 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 10 | 0.250 |
Why?
| | Relaxin | 2 | 2018 | 18 | 0.250 |
Why?
| | Neuropeptides | 3 | 2018 | 74 | 0.250 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 37 | 0.250 |
Why?
| | Allosteric Site | 1 | 2007 | 17 | 0.250 |
Why?
| | Age Factors | 7 | 2021 | 3329 | 0.250 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 268 | 0.250 |
Why?
| | Vaccines | 1 | 2012 | 388 | 0.250 |
Why?
| | Receptors, Interleukin-6 | 2 | 2024 | 47 | 0.250 |
Why?
| | Limbic System | 1 | 2007 | 55 | 0.250 |
Why?
| | Maze Learning | 6 | 2021 | 105 | 0.240 |
Why?
| | Restraint, Physical | 4 | 2015 | 75 | 0.240 |
Why?
| | Histamine | 2 | 2006 | 53 | 0.240 |
Why?
| | Up-Regulation | 4 | 2012 | 848 | 0.240 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 19 | 0.240 |
Why?
| | Indomethacin | 1 | 2006 | 76 | 0.230 |
Why?
| | Biguanides | 1 | 2005 | 10 | 0.230 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 82 | 0.230 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 16 | 0.230 |
Why?
| | Telemetry | 2 | 2017 | 40 | 0.230 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 137 | 0.230 |
Why?
| | In Situ Hybridization | 5 | 2012 | 318 | 0.230 |
Why?
| | Prolactin | 2 | 2005 | 87 | 0.230 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 3 | 0.230 |
Why?
| | Benzodiazepines | 1 | 2007 | 168 | 0.230 |
Why?
| | Adult | 24 | 2025 | 40489 | 0.220 |
Why?
| | Environmental Microbiology | 2 | 2019 | 57 | 0.220 |
Why?
| | Microdialysis | 6 | 2025 | 56 | 0.220 |
Why?
| | Vimentin | 1 | 2005 | 54 | 0.220 |
Why?
| | Adrenal Medulla | 1 | 2004 | 10 | 0.210 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 146 | 0.210 |
Why?
| | Onchocerciasis | 2 | 2001 | 8 | 0.210 |
Why?
| | Life Change Events | 1 | 2005 | 147 | 0.210 |
Why?
| | Healthy Aging | 1 | 2024 | 40 | 0.210 |
Why?
| | Criminology | 1 | 2024 | 2 | 0.210 |
Why?
| | Glucans | 1 | 2024 | 22 | 0.210 |
Why?
| | Dopamine | 3 | 2018 | 291 | 0.210 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.210 |
Why?
| | Insect Vectors | 2 | 2001 | 39 | 0.210 |
Why?
| | Progesterone | 2 | 2025 | 209 | 0.210 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 15 | 0.200 |
Why?
| | Oligosaccharides | 1 | 2024 | 60 | 0.200 |
Why?
| | Helicobacter Infections | 2 | 2021 | 30 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 100 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 163 | 0.200 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 68 | 0.200 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 396 | 0.200 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 2 | 0.200 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 33 | 0.200 |
Why?
| | Specimen Handling | 1 | 2025 | 187 | 0.200 |
Why?
| | Estrogens | 2 | 2025 | 364 | 0.200 |
Why?
| | Diazepam | 1 | 2023 | 33 | 0.200 |
Why?
| | Cerebral Cortex | 1 | 2007 | 470 | 0.200 |
Why?
| | Macrophages | 2 | 2023 | 1496 | 0.190 |
Why?
| | Middle Aged | 16 | 2025 | 35971 | 0.190 |
Why?
| | Leptin | 1 | 2024 | 247 | 0.190 |
Why?
| | Friends | 1 | 2023 | 57 | 0.180 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 6 | 0.180 |
Why?
| | Administration, Oral | 1 | 2025 | 851 | 0.180 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 245 | 0.180 |
Why?
| | Random Allocation | 4 | 2009 | 366 | 0.180 |
Why?
| | Mucins | 1 | 2022 | 75 | 0.180 |
Why?
| | Planets | 1 | 2021 | 1 | 0.180 |
Why?
| | Norepinephrine | 5 | 2005 | 196 | 0.180 |
Why?
| | Estradiol | 2 | 2025 | 507 | 0.180 |
Why?
| | Coinfection | 1 | 2023 | 141 | 0.180 |
Why?
| | Hydrazines | 3 | 2018 | 37 | 0.170 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 30 | 0.170 |
Why?
| | Neopterin | 2 | 2022 | 13 | 0.170 |
Why?
| | Hygiene | 2 | 2014 | 29 | 0.170 |
Why?
| | Populus | 1 | 2021 | 15 | 0.170 |
Why?
| | Helicobacter pylori | 1 | 2021 | 45 | 0.170 |
Why?
| | Insect Bites and Stings | 1 | 2001 | 13 | 0.170 |
Why?
| | Piperazines | 3 | 2010 | 378 | 0.170 |
Why?
| | Adrenalectomy | 2 | 2015 | 68 | 0.170 |
Why?
| | Cholera Toxin | 3 | 2013 | 29 | 0.170 |
Why?
| | Brain Stem | 3 | 2006 | 97 | 0.160 |
Why?
| | Groundwater | 1 | 2021 | 41 | 0.160 |
Why?
| | Diptera | 1 | 2001 | 31 | 0.160 |
Why?
| | Epinephrine | 2 | 2005 | 154 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2005 | 733 | 0.160 |
Why?
| | Escape Reaction | 2 | 2017 | 55 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2025 | 431 | 0.160 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 8 | 0.160 |
Why?
| | Frailty | 1 | 2024 | 200 | 0.160 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1046 | 0.160 |
Why?
| | United States | 7 | 2025 | 16018 | 0.160 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.160 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 34 | 0.150 |
Why?
| | Adiposity | 1 | 2024 | 529 | 0.150 |
Why?
| | Neuropsychiatry | 1 | 2020 | 17 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 231 | 0.150 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 55 | 0.150 |
Why?
| | Multiple Trauma | 1 | 2021 | 121 | 0.150 |
Why?
| | Shock | 1 | 2021 | 108 | 0.150 |
Why?
| | Urban Population | 2 | 2025 | 493 | 0.150 |
Why?
| | Autoradiography | 2 | 2009 | 66 | 0.150 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 337 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2025 | 586 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2022 | 166 | 0.150 |
Why?
| | Periodontitis | 1 | 2020 | 54 | 0.150 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 3 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 84 | 0.150 |
Why?
| | Psycholinguistics | 1 | 2019 | 20 | 0.150 |
Why?
| | Individuality | 2 | 2019 | 149 | 0.150 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 641 | 0.140 |
Why?
| | Phobic Disorders | 1 | 2019 | 35 | 0.140 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 52 | 0.140 |
Why?
| | Memory, Episodic | 1 | 2019 | 55 | 0.140 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 13 | 0.140 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 771 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 368 | 0.140 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.140 |
Why?
| | Alarmins | 1 | 2018 | 27 | 0.140 |
Why?
| | Yohimbine | 2 | 2010 | 11 | 0.140 |
Why?
| | Health Promotion | 1 | 2024 | 771 | 0.140 |
Why?
| | Housing | 1 | 2019 | 147 | 0.130 |
Why?
| | HMGB1 Protein | 1 | 2018 | 51 | 0.130 |
Why?
| | MicroRNAs | 2 | 2014 | 689 | 0.130 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 15 | 0.130 |
Why?
| | Adiponectin | 1 | 2020 | 240 | 0.130 |
Why?
| | Vasopressins | 1 | 1998 | 60 | 0.130 |
Why?
| | Nervous System | 1 | 1998 | 69 | 0.130 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 58 | 0.130 |
Why?
| | Grooming | 2 | 2009 | 9 | 0.130 |
Why?
| | Nesting Behavior | 1 | 2018 | 19 | 0.130 |
Why?
| | Mice, Knockout | 4 | 2019 | 3109 | 0.130 |
Why?
| | Vertebrates | 1 | 1998 | 67 | 0.130 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.130 |
Why?
| | Phenylalanine | 1 | 2018 | 70 | 0.130 |
Why?
| | Amphibians | 1 | 1998 | 56 | 0.130 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 410 | 0.130 |
Why?
| | Desipramine | 2 | 2015 | 10 | 0.130 |
Why?
| | Tyrosine | 1 | 2018 | 219 | 0.130 |
Why?
| | Genetic Fitness | 1 | 2018 | 59 | 0.130 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 130 | 0.130 |
Why?
| | Noise | 1 | 2018 | 72 | 0.130 |
Why?
| | Food Chain | 1 | 2017 | 46 | 0.130 |
Why?
| | Helicobacter | 1 | 2016 | 3 | 0.130 |
Why?
| | Songbirds | 1 | 2018 | 46 | 0.130 |
Why?
| | Biomarkers | 3 | 2024 | 4261 | 0.130 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.120 |
Why?
| | Hydrocortisone | 2 | 2018 | 297 | 0.120 |
Why?
| | Tissue Distribution | 3 | 2006 | 335 | 0.120 |
Why?
| | Altitude | 1 | 2021 | 473 | 0.120 |
Why?
| | Pilot Projects | 2 | 2024 | 1886 | 0.120 |
Why?
| | Soil Microbiology | 1 | 2019 | 218 | 0.120 |
Why?
| | Impulsive Behavior | 1 | 2018 | 143 | 0.120 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 590 | 0.120 |
Why?
| | Psychomotor Performance | 1 | 2019 | 328 | 0.120 |
Why?
| | Down-Regulation | 1 | 2018 | 616 | 0.120 |
Why?
| | Immunity, Cellular | 1 | 2018 | 272 | 0.120 |
Why?
| | Global Health | 1 | 2019 | 401 | 0.120 |
Why?
| | Drug Administration Routes | 2 | 2007 | 42 | 0.120 |
Why?
| | Species Specificity | 3 | 2023 | 573 | 0.120 |
Why?
| | Video Recording | 2 | 2009 | 217 | 0.120 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.120 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
| | Obesity | 3 | 2024 | 3070 | 0.120 |
Why?
| | Young Adult | 7 | 2025 | 14122 | 0.120 |
Why?
| | Rectum | 1 | 2017 | 183 | 0.120 |
Why?
| | Adrenal Glands | 2 | 2016 | 76 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1268 | 0.110 |
Why?
| | Affect | 1 | 2018 | 322 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 706 | 0.110 |
Why?
| | Epilepsy | 1 | 2020 | 386 | 0.110 |
Why?
| | Radioimmunoassay | 2 | 2009 | 165 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 572 | 0.110 |
Why?
| | Staining and Labeling | 2 | 2006 | 153 | 0.110 |
Why?
| | Membrane Potentials | 1 | 1996 | 278 | 0.110 |
Why?
| | Cohort Studies | 3 | 2024 | 5957 | 0.110 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 24 | 0.110 |
Why?
| | Receptors, Steroid | 1 | 1995 | 41 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 81 | 0.110 |
Why?
| | Argonaute Proteins | 1 | 2014 | 32 | 0.110 |
Why?
| | Learning | 1 | 2019 | 448 | 0.110 |
Why?
| | Extracellular Space | 2 | 2019 | 119 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 187 | 0.110 |
Why?
| | Diet | 4 | 2024 | 1270 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5870 | 0.100 |
Why?
| | Urbanization | 1 | 2014 | 29 | 0.100 |
Why?
| | Chronic Disease | 2 | 2019 | 1810 | 0.100 |
Why?
| | White Matter | 1 | 2016 | 153 | 0.100 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 11 | 0.100 |
Why?
| | Quality of Life | 2 | 2024 | 3183 | 0.100 |
Why?
| | Proteins | 1 | 2020 | 1016 | 0.100 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 58 | 0.100 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 31 | 0.100 |
Why?
| | Respiration Disorders | 1 | 2014 | 78 | 0.100 |
Why?
| | Bradycardia | 2 | 2012 | 61 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1193 | 0.100 |
Why?
| | Receptors, Opioid | 2 | 1990 | 21 | 0.100 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 11 | 0.100 |
Why?
| | Biological Evolution | 2 | 2014 | 488 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2020 | 622 | 0.100 |
Why?
| | Comorbidity | 2 | 2017 | 1652 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 835 | 0.100 |
Why?
| | Seasons | 3 | 2020 | 556 | 0.100 |
Why?
| | Sleep | 4 | 2021 | 890 | 0.100 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 15 | 0.100 |
Why?
| | Rural Population | 1 | 2018 | 657 | 0.100 |
Why?
| | Emigration and Immigration | 1 | 2014 | 66 | 0.100 |
Why?
| | Rodentia | 1 | 2013 | 62 | 0.090 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 147 | 0.090 |
Why?
| | Body Weight | 1 | 2017 | 968 | 0.090 |
Why?
| | Avoidance Learning | 1 | 2013 | 63 | 0.090 |
Why?
| | Skin | 3 | 2023 | 762 | 0.090 |
Why?
| | Amphetamine | 1 | 2012 | 38 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2018 | 5414 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7122 | 0.090 |
Why?
| | Angiotensin II | 1 | 2013 | 95 | 0.090 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.090 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.090 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 464 | 0.090 |
Why?
| | Weaning | 1 | 2012 | 51 | 0.090 |
Why?
| | Resilience, Psychological | 1 | 2014 | 149 | 0.090 |
Why?
| | Brain Injuries | 1 | 2017 | 506 | 0.090 |
Why?
| | Phenotype | 3 | 2021 | 3147 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 639 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2002 | 118 | 0.080 |
Why?
| | Metagenomics | 2 | 2024 | 183 | 0.080 |
Why?
| | Hypertension | 2 | 2012 | 1262 | 0.080 |
Why?
| | Memory | 3 | 2018 | 296 | 0.080 |
Why?
| | Electroshock | 3 | 2017 | 145 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 138 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2137 | 0.080 |
Why?
| | Aged | 5 | 2024 | 25955 | 0.080 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 20 | 0.080 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 3 | 0.080 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 177 | 0.080 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 18 | 0.080 |
Why?
| | Sanitation | 1 | 2010 | 56 | 0.080 |
Why?
| | Radiography | 1 | 2013 | 848 | 0.080 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 187 | 0.080 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 115 | 0.080 |
Why?
| | Cell Lineage | 1 | 2012 | 376 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2014 | 574 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 97 | 0.070 |
Why?
| | Social Dominance | 1 | 2009 | 16 | 0.070 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 72 | 0.070 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 407 | 0.070 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.070 |
Why?
| | Feeding Behavior | 2 | 2006 | 686 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3148 | 0.070 |
Why?
| | Thermosensing | 1 | 2008 | 12 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 454 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2136 | 0.070 |
Why?
| | Transfection | 1 | 2011 | 924 | 0.070 |
Why?
| | Pargyline | 1 | 2008 | 3 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1134 | 0.070 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 11 | 0.070 |
Why?
| | Biological Transport | 2 | 2006 | 418 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 412 | 0.070 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 171 | 0.070 |
Why?
| | Mice, Transgenic | 4 | 2014 | 2184 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2010 | 381 | 0.070 |
Why?
| | Temperature | 1 | 2011 | 680 | 0.070 |
Why?
| | Pyridines | 2 | 2013 | 603 | 0.070 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 185 | 0.070 |
Why?
| | Somatoform Disorders | 1 | 2007 | 34 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 332 | 0.070 |
Why?
| | Self Report | 2 | 2024 | 869 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2008 | 284 | 0.060 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 9 | 0.060 |
Why?
| | Exercise | 2 | 2024 | 2183 | 0.060 |
Why?
| | Tryptamines | 1 | 2006 | 5 | 0.060 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 140 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 732 | 0.060 |
Why?
| | Synapses | 1 | 2010 | 437 | 0.060 |
Why?
| | Darkness | 1 | 2006 | 26 | 0.060 |
Why?
| | Genotype | 3 | 2020 | 1847 | 0.060 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 5 | 0.060 |
Why?
| | Heart Rate | 2 | 2025 | 853 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1374 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2005 | 36 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 691 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 706 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 444 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 401 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 45 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 5 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 12 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 9 | 0.060 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 155 | 0.060 |
Why?
| | Injections | 1 | 2005 | 197 | 0.050 |
Why?
| | Blood Pressure | 2 | 2013 | 1766 | 0.050 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 34 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 779 | 0.050 |
Why?
| | Heart Atria | 1 | 2005 | 141 | 0.050 |
Why?
| | Autoimmunity | 1 | 2010 | 930 | 0.050 |
Why?
| | Microinjections | 2 | 2015 | 92 | 0.050 |
Why?
| | Neurons, Efferent | 1 | 2004 | 9 | 0.050 |
Why?
| | Mind-Body Therapies | 1 | 2024 | 9 | 0.050 |
Why?
| | Nerve Fibers | 1 | 2005 | 105 | 0.050 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 26 | 0.050 |
Why?
| | Lomustine | 1 | 2024 | 15 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 163 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 180 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4558 | 0.050 |
Why?
| | Brazil | 2 | 2001 | 182 | 0.050 |
Why?
| | Perfusion | 1 | 2005 | 249 | 0.050 |
Why?
| | Mouth | 1 | 2024 | 88 | 0.050 |
Why?
| | Risk Factors | 3 | 2025 | 10796 | 0.050 |
Why?
| | Criminal Law | 1 | 2024 | 30 | 0.050 |
Why?
| | Crime | 1 | 2024 | 59 | 0.050 |
Why?
| | Metagenome | 1 | 2024 | 149 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3414 | 0.050 |
Why?
| | Spleen | 1 | 2025 | 510 | 0.050 |
Why?
| | Action Potentials | 2 | 2011 | 502 | 0.050 |
Why?
| | Saliva | 1 | 2025 | 247 | 0.050 |
Why?
| | Drosophila Proteins | 2 | 2002 | 213 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 104 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 221 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 539 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 281 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 4 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 11 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 9 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1161 | 0.050 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 150 | 0.050 |
Why?
| | Fever | 1 | 2024 | 313 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 51 | 0.040 |
Why?
| | Blood Glucose | 2 | 2011 | 2326 | 0.040 |
Why?
| | Models, Biological | 2 | 2007 | 1811 | 0.040 |
Why?
| | Bacteroidetes | 1 | 2021 | 21 | 0.040 |
Why?
| | Eye | 1 | 2002 | 110 | 0.040 |
Why?
| | Simuliidae | 1 | 2001 | 1 | 0.040 |
Why?
| | Polysomnography | 2 | 2019 | 236 | 0.040 |
Why?
| | Counseling | 1 | 2024 | 405 | 0.040 |
Why?
| | Endophenotypes | 1 | 2021 | 22 | 0.040 |
Why?
| | Anhedonia | 1 | 2021 | 17 | 0.040 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 210 | 0.040 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 23 | 0.040 |
Why?
| | Granulocytes | 1 | 2021 | 81 | 0.040 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 87 | 0.040 |
Why?
| | Social Justice | 1 | 2022 | 82 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2022 | 136 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 249 | 0.040 |
Why?
| | Trees | 1 | 2021 | 67 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2021 | 50 | 0.040 |
Why?
| | Rivers | 1 | 2021 | 68 | 0.040 |
Why?
| | Dreams | 1 | 2000 | 14 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 232 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 975 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 277 | 0.040 |
Why?
| | Policy | 1 | 2022 | 147 | 0.040 |
Why?
| | Cations | 1 | 2021 | 82 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 552 | 0.040 |
Why?
| | Microelectrodes | 1 | 2000 | 48 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 222 | 0.040 |
Why?
| | Choice Behavior | 1 | 2022 | 179 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 1774 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Program Evaluation | 1 | 2024 | 941 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 41 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 650 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 158 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 97 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 112 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 1103 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 81 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 96 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 507 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 4 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2033 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 379 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 253 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 93 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 93 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 618 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 399 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 264 | 0.040 |
Why?
| | Axons | 1 | 2000 | 203 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 103 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 545 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 438 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2001 | 278 | 0.040 |
Why?
| | Genetic Testing | 1 | 2001 | 480 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 374 | 0.030 |
Why?
| | Serologic Tests | 1 | 2018 | 53 | 0.030 |
Why?
| | Patient Care Team | 1 | 2024 | 690 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 565 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 198 | 0.030 |
Why?
| | Extracellular Fluid | 2 | 2010 | 38 | 0.030 |
Why?
| | Agoraphobia | 1 | 2017 | 8 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 170 | 0.030 |
Why?
| | Feathers | 1 | 2018 | 36 | 0.030 |
Why?
| | Metabolome | 1 | 2021 | 385 | 0.030 |
Why?
| | Electroencephalography | 1 | 2021 | 555 | 0.030 |
Why?
| | Germany | 1 | 2018 | 138 | 0.030 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 2 | 0.030 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.030 |
Why?
| | Thionucleotides | 1 | 1997 | 35 | 0.030 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 47 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2018 | 215 | 0.030 |
Why?
| | Body Size | 1 | 2018 | 94 | 0.030 |
Why?
| | Picrotoxin | 1 | 2017 | 12 | 0.030 |
Why?
| | Biodiversity | 1 | 2021 | 425 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 438 | 0.030 |
Why?
| | Oxytocin | 1 | 1997 | 51 | 0.030 |
Why?
| | Nerve Net | 1 | 2020 | 284 | 0.030 |
Why?
| | Quinolines | 2 | 2010 | 192 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 81 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 75 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 2 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 14 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 75 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 461 | 0.030 |
Why?
| | Attention | 1 | 2019 | 458 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 311 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 681 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 11735 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 496 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 651 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 831 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 10 | 0.030 |
Why?
| | Environment | 1 | 2017 | 306 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 53 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 27 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 820 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 113 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 460 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1182 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 55 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 254 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 365 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 38 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 319 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 141 | 0.020 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 9 | 0.020 |
Why?
| | Memory Disorders | 1 | 2014 | 196 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 625 | 0.020 |
Why?
| | Heterozygote | 1 | 2014 | 313 | 0.020 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.020 |
Why?
| | Mothers | 1 | 1999 | 765 | 0.020 |
Why?
| | Cues | 1 | 2015 | 326 | 0.020 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 38 | 0.020 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 567 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1076 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1700 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 7994 | 0.020 |
Why?
| | Orexins | 1 | 2012 | 6 | 0.020 |
Why?
| | Androgens | 1 | 1994 | 178 | 0.020 |
Why?
| | Naphthyridines | 1 | 2012 | 20 | 0.020 |
Why?
| | Benzoxazoles | 1 | 2012 | 19 | 0.020 |
Why?
| | Naloxone | 2 | 1990 | 131 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2104 | 0.020 |
Why?
| | Eye Proteins | 2 | 2002 | 85 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 246 | 0.020 |
Why?
| | Urea | 1 | 2012 | 84 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 339 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2942 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 206 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 58 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 295 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 330 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 8 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 66 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 126 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 169 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 1 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 26 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 26 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1348 | 0.020 |
Why?
| | Pain | 1 | 2013 | 785 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 277 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 165 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4110 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 213 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 81 | 0.020 |
Why?
| | Child | 2 | 2019 | 22600 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 12 | 0.010 |
Why?
| | Ranitidine | 1 | 1986 | 14 | 0.010 |
Why?
| | Neural Inhibition | 1 | 2007 | 178 | 0.010 |
Why?
| | Growth Hormone | 1 | 1986 | 91 | 0.010 |
Why?
| | Testis | 1 | 1986 | 162 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 427 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 519 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22409 | 0.010 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 3 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2350 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 319 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4081 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 794 | 0.010 |
Why?
| | 5' Flanking Region | 1 | 2001 | 9 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 393 | 0.010 |
Why?
| | Insect Proteins | 1 | 2001 | 41 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 273 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 150 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2001 | 155 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 58 | 0.010 |
Why?
| | Introns | 1 | 2001 | 255 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 507 | 0.010 |
Why?
| | Exons | 1 | 2001 | 362 | 0.010 |
Why?
| | Drosophila | 1 | 2001 | 167 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 199 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 80 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17149 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2909 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 13 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 11 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 48 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 306 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 2419 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 412 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 6041 | 0.000 |
Why?
| | Dyspepsia | 1 | 1986 | 11 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 360 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 143 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2502 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|